Free Trial

Arrowhead Pharmaceuticals (ARWR) Short Interest Ratio & Short Volume

$22.87
-1.05 (-4.39%)
(As of 05/29/2024 ET)

Arrowhead Pharmaceuticals Short Interest Data

Current Short Interest
9,340,000 shares
Previous Short Interest
9,610,000 shares
Change Vs. Previous Month
-2.81%
Dollar Volume Sold Short
$233.87 million
Short Interest Ratio
7.8 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
124,200,000 shares
Percentage of Shares Shorted
7.52%
Today's Trading Volume
1,038,916 shares
Average Trading Volume
960,811 shares
Today's Volume Vs. Average
108%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Arrowhead Pharmaceuticals ?

Sign up to receive the latest short interest report for Arrowhead Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ARWR Short Interest Over Time

ARWR Days to Cover Over Time

ARWR Percentage of Float Shorted Over Time

Arrowhead Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20249,340,000 shares $233.87 million -2.8%N/A7.8 $25.04
4/30/20249,610,000 shares $217.38 million +8.3%N/A7.7 $22.62
4/15/20248,870,000 shares $212.97 million No ChangeN/A7.1 $24.01
3/31/20248,870,000 shares $253.68 million -3.6%N/A6.2 $28.60
3/15/20249,200,000 shares $260.18 million +4.1%N/A5.8 $28.28
2/29/20248,840,000 shares $283.76 million +0.8%N/A5.5 $32.10
2/15/20248,770,000 shares $259.33 million +13.6%N/A5.4 $29.57
1/31/20247,720,000 shares $247.81 million -13.0%N/A5 $32.10
1/15/20248,870,000 shares $323.13 million +18.7%8.8%5.8 $36.43
12/31/20237,470,000 shares $228.58 million -3.5%7.4%5 $30.60
12/15/20237,740,000 shares $220.98 million +1.6%7.7%6.3 $28.55
11/30/20237,620,000 shares $161.54 million -3.3%7.5%6.5 $21.20
11/15/20237,880,000 shares $212.84 million +9.9%7.8%7.9 $27.01
10/31/20237,170,000 shares $176.31 million +0.6%7.1%7.5 $24.59
10/15/20237,130,000 shares $189.66 million +19.0%7.0%7.5 $26.60
9/30/20235,990,000 shares $160.95 million -1.8%5.9%6.6 $26.87
9/15/20236,100,000 shares $176.41 million -3.6%6.0%6.7 $28.92
8/31/20236,330,000 shares $174.96 million +4.5%6.3%7.1 $27.64
8/15/20236,060,000 shares $177.86 million +8.8%6.0%6.8 $29.35
7/31/20235,570,000 shares $192.28 million +8.0%5.5%6.1 $34.52
7/15/20235,160,000 shares $178.54 million +9.3%5.0%5.2 $34.60
6/30/20234,720,000 shares $168.32 million -5.4%4.6%4.6 $35.66
6/15/20234,990,000 shares $178.34 million +1.0%4.9%5 $35.74
5/31/20234,940,000 shares $169.99 million -5.5%4.8%4.4 $34.41
5/15/20235,230,000 shares $208.62 million +8.1%5.1%4.5 $39.89
4/30/20234,840,000 shares $171.38 million -0.8%4.7%4.2 $35.41
4/15/20234,880,000 shares $148.64 million -1.6%4.7%4.7 $30.46
3/31/20234,960,000 shares $125.98 million -9.8%4.8%4.5 $25.40
3/15/20235,500,000 shares $139.26 million +19.1%5.3%4.9 $25.32
2/28/20234,620,000 shares $149.23 million -2.5%4.4%4.7 $32.30
2/15/20234,740,000 shares $161.40 million +3.5%4.6%4.9 $34.05
1/31/20234,580,000 shares $160.25 million -0.7%4.5%4.4 $34.99
1/15/20234,610,000 shares $169.74 million -2.7%4.5%4.6 $36.82
12/30/20224,740,000 shares $192.25 million +11.8%4.6%5 $40.56
12/15/20224,240,000 shares $133.31 million +7.1%4.2%4.8 $31.44
11/30/20223,960,000 shares $127.51 million +6.2%3.8%4.6 $32.20
11/15/20223,730,000 shares $125.55 million -4.4%3.6%4.5 $33.66
10/31/20223,900,000 shares $135.76 million -1.0%3.8%5 $34.81
10/15/20223,940,000 shares $126.16 million +1.8%3.9%5.1 $32.02
9/30/20223,870,000 shares $127.90 million -9.2%3.8%5.1 $33.05
The only AI company to buy (Ad)

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.
9/15/20224,260,000 shares $149.65 million +1.9%4.2%5.4 $35.13
8/31/20224,180,000 shares $165.99 million -4.4%4.1%5.2 $39.71
8/15/20224,370,000 shares $211.11 million -9.5%4.3%5.5 $48.31
7/31/20224,830,000 shares $205.42 million -2.0%4.7%5.3 $42.53
7/15/20224,930,000 shares $211.00 million -7.2%4.8%5.6 $42.80
6/30/20225,310,000 shares $186.97 million +6.6%5.2%6.1 $35.21
6/15/20224,980,000 shares $145.37 million +11.4%6.1%5.8 $29.19
5/31/20224,470,000 shares $149.12 million -5.9%4.4%5.7 $33.36
5/15/20224,750,000 shares $150.29 million +18.8%4.7%6 $31.64
4/30/20224,000,000 shares $164.44 million +9.0%4.0%5.5 $41.11
4/15/20223,670,000 shares $172.01 million -7.1%3.7%5.1 $46.87
3/31/20223,950,000 shares $181.66 million +2.6%4.0%5.5 $45.99
3/15/20223,850,000 shares $156.77 million +14.6%3.9%5.6 $40.72
2/28/20223,360,000 shares $147.84 million +8.4%3.4%4.8 $44.00
2/15/20223,100,000 shares $155.68 million +7.6%3.2%4.4 $50.22
1/31/20222,880,000 shares $151.95 million +3.2%3.0%4.1 $52.76
1/15/20222,790,000 shares $161.29 million +4.5%2.9%4.2 $57.81
12/31/20212,670,000 shares $177.02 million -15.2%2.8%4.2 $66.30
12/15/20213,150,000 shares $221.60 million +10.5%3.3%5.1 $70.35
11/30/20212,850,000 shares $199.64 million -5.6%3.0%4.9 $70.05
11/15/20213,020,000 shares $199.02 million +4.5%3.2%5.4 $65.90
10/29/20212,890,000 shares $184.44 million No Change3.0%5.7 $63.82
10/15/20212,890,000 shares $191.20 million -9.7%3.0%5.5 $66.16
9/30/20213,200,000 shares $199.78 million +10.0%3.3%5.7 $62.43
9/15/20212,910,000 shares $184.81 million -6.4%3.0%3.8 $63.51
8/31/20213,110,000 shares $208.74 million +0.7%3.2%3.8 $67.12
8/13/20213,090,000 shares $187.01 million -11.2%3.2%3.5 $60.52
7/30/20213,480,000 shares $241.13 million +4.8%3.6%3.9 $69.29
7/15/20213,320,000 shares $209.66 million -9.8%3.4%3.7 $63.15
6/30/20213,680,000 shares $304.78 million -17.3%3.8%4.1 $82.82
6/15/20214,450,000 shares $385.50 million -7.7%4.6%6.2 $86.63
5/28/20214,820,000 shares $349.93 million +0.2%5.0%6.7 $72.60
5/14/20214,810,000 shares $326.50 million +3.4%N/A6.4 $67.88
4/30/20214,650,000 shares $352.28 million -3.1%N/A6.1 $75.76
4/15/20214,800,000 shares $322.42 million -1.4%N/A6.2 $67.17
3/31/20214,870,000 shares $310.17 million -5.1%N/A6.1 $63.69
3/15/20215,130,000 shares $373.16 million -0.2%N/A5.8 $72.74
2/26/20215,140,000 shares $422.51 million +2.4%N/A5.7 $82.20
2/12/20215,020,000 shares $443.47 million +1.2%N/A5.2 $88.34
1/29/20214,960,000 shares $385.64 million -5.2%N/A5.1 $77.75
1/15/20215,230,000 shares $433.36 million -11.2%5.6%5.1 $82.86
12/31/20205,890,000 shares $456.06 million -20.3%6.3%5.1 $77.43
12/15/20207,390,000 shares $553.58 million -5.6%7.9%6.3 $74.91
11/30/20207,830,000 shares $493.21 million -4.5%8.3%4.8 $62.99
11/15/20208,200,000 shares $562.03 million -1.3%8.7%5.1 $68.54
10/30/20208,310,000 shares $482.73 million -10.9%8.9%5.4 $58.09
10/15/20209,330,000 shares $414.81 million +3.6%10.0%6.2 $44.46
9/30/20209,010,000 shares $387.97 million -0.7%9.6%6.3 $43.06
9/15/20209,070,000 shares $306.57 million -3.7%9.7%6.3 $33.80
8/31/20209,420,000 shares $397.90 million -1.0%10.1%9.1 $42.24
The only AI company to buy (Ad)

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.
8/14/20209,510,000 shares $399.52 million -3.3%10.2%9.1 $42.01
7/31/20209,830,000 shares $423.38 million -4.6%10.5%8.9 $43.07
7/15/202010,300,000 shares $496.25 million +3.1%11.1%9 $48.18
6/30/20209,990,000 shares $431.47 million +18.9%10.8%8.3 $43.19
6/15/20208,400,000 shares $279.05 million +0.8%9.1%6.7 $33.22
5/29/20208,330,000 shares $268.56 million +3.6%9.0%5.7 $32.24
5/15/20208,040,000 shares $288.23 million +0.9%8.7%5.2 $35.85
4/30/20207,970,000 shares $274.41 million +4.3%8.6%5.1 $34.43
4/15/20207,640,000 shares $269.92 million -0.4%8.3%4.6 $35.33
3/31/20207,670,000 shares $298.29 million -7.3%8.3%4.4 $38.89
3/13/20208,270,900 shares $280.14 million -5.2%8.9%5.2 $33.87
2/28/20208,720,000 shares $223.06 million -8.5%9.4%4.5 $25.58
2/14/20209,530,000 shares $284.85 million -4.5%10.3%4.1 $29.89
1/31/20209,980,000 shares $359.88 million -9.0%10.6%4.1 $36.06
1/15/202010,970,000 shares $456.13 million -1.4%11.7%4.6 $41.58
12/31/201911,120,000 shares $496.06 million -8.9%12.0%4.9 $44.61

ARWR Short Interest - Frequently Asked Questions

What is Arrowhead Pharmaceuticals' current short interest?

Short interest is the volume of Arrowhead Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 9,340,000 shares of ARWR short. Learn More on Arrowhead Pharmaceuticals' current short interest.

What is a good short interest ratio for Arrowhead Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ARWR shares currently have a short interest ratio of 8.0. Learn More on Arrowhead Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Arrowhead Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Arrowhead Pharmaceuticals: Walleye Trading LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Arrowhead Pharmaceuticals' short interest increasing or decreasing?

Arrowhead Pharmaceuticals saw a decline in short interest in May. As of May 15th, there was short interest totaling 9,340,000 shares, a decline of 2.8% from the previous total of 9,610,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Arrowhead Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Arrowhead Pharmaceuticals: ACADIA Pharmaceuticals Inc. (7.25%), Bausch Health Companies Inc. (5.17%), United Therapeutics Co. (9.14%), Sarepta Therapeutics, Inc. (6.94%), Dr. Reddy's Laboratories Limited (0.58%), Catalent, Inc. (3.76%), Roivant Sciences Ltd. (7.02%), Elanco Animal Health Incorporated (3.43%), Ascendis Pharma A/S (5.94%), Legend Biotech Co. (7.12%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Arrowhead Pharmaceuticals stock?

Short selling ARWR is an investing strategy that aims to generate trading profit from Arrowhead Pharmaceuticals as its price is falling. ARWR shares are trading down $1.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Arrowhead Pharmaceuticals?

A short squeeze for Arrowhead Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ARWR, which in turn drives the price of the stock up even further.

How often is Arrowhead Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARWR, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ARWR) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners